Cross-Resistance to UV Radiation of a Cisplatin-Resistant Human Cell Line: Overexpression of Cellular Factors That Recognize UV-Modified DNA

REFERENCES

• Behrens, B. C., T. C. Hamilton, H. Masuda, K. R. Grotzinger, J. Whang-Peng, K. G. Louie, T. Knutsen, W. M. McKoy, R. C. Young, and R. F. Ozols. 1987. Characterization of a cis-diam- minedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res. 47:414–418.
   PubMed Web of Science ®Google Scholar
• Bird, P., M.-J. Gething, and J. Sambrook. 1987. Translocation in yeast and mammalian cells: not all signal sequences are functionally equivalent. J. Cell Biol. 105:2905–2914.
   PubMedGoogle Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Carthew, R. W., L. Chodosh, and P. Sharp. 1985. An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell 43:439–448.
   PubMed Web of Science ®Google Scholar
• Chao, C. C.-K. et al. Submitted for publication.
   Google Scholar
• Chao, C. C.-K., S.-L. Huang, H. Huang, S. Lin-Chao. Unpublished observation.
   Google Scholar
• Chao, C. C.-K., Y.-L. Lee, P.-W. Cheng, and S. Lin-Chao. 1991. Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to czs-diamminedichloroplatinum(II). Cancer Res. 51:601–605.
   PubMedGoogle Scholar
• Chao, C. C.-K., and B. S. Rosenstein. 1985. Induction of sister-chromatid exchanges in ICR 2A frog cells exposed to 254 nm and solar wavelengths. Photochem. Photobiol. 41:625–627.
   PubMedGoogle Scholar
• Chu, G., and P. Berg. 1987. DNA cross-linked by cisplatin: a new probe for the DNA repair defect in xeroderma pigmentosum. Mol. Biol. Med. 4:277–290.
   PubMedGoogle Scholar
• Chu, G., and E. Chang. 1988. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science 242:564–567.
   PubMedGoogle Scholar
• Chu, G., and E. Chang. 1990. Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. Proc. Natl. Acad. Sci. USA 87:3324–3327.
   PubMed Web of Science ®Google Scholar
• Chu, G., H. Hayakawa, and P. Berg. 1987. Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res. 15:1311–1326.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Eastman, A., and N. Schulte. 1988. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). Biochemistry 27:4730–4734.
   PubMed Web of Science ®Google Scholar
• Endicott, J. A., and V. Ling. 1989. The biochemistry of P-gly- coprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:137–171.
   PubMed Web of Science ®Google Scholar
• Frei, E., HI, C. A. Cucchi, A. Rosowsky, R. Tantravahi, S. Bernal, T. J. Ervin, R. M. Ruprecht, and W. A. Haseltine. 1985. Alkylating agent resistance: In vitro studies with human cell lines. Proc. Natl. Acad. Sci. USA 82:2158–2162.
   PubMed Web of Science ®Google Scholar
• Friedberg, E. C. 1985. DNA repair. W. H. Freeman & Co., New York.
   Google Scholar
• Fry, D. W., and R. C. Jackson. 1986. Membrane transport alterations as a mechanism of resistance to anticancer agents. Cancer Surv. 5:47–79.
   PubMedGoogle Scholar
• Gorman, C. M., G. T. Merino, M. C. Williagham, I. Pastan, and B. H. Howard. 1982. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl. Acad. Sci. USA 79:6777–6781.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Hamilton, T. C., M. A. Winker, K. G. Louie, G. Batist, B. C. Behrens, T. Tsuruo, K. R. Grotzinger, W. M. McKoy, R. C. Young, and R. F. Ozols. 1985. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug resistant and sensitive human ovarian cancer cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem. Pharmacol. 34:2583–2586.
   PubMed Web of Science ®Google Scholar
• Hannighausen, L., and H. Lubon. 1987. Interaction of protein with DNA in vitro. Methods Enzymol. 152:721–735.
   PubMedGoogle Scholar
• Hospers, G. A. P., N. H. Mulder, and E. G. E. De Vries. 1988. Mechanisms of cellular resistance to cisplatin. Med. Oncol. Tumor Pharmacother. 5:145–151.
   PubMedGoogle Scholar
• Klocker, H., R. Schneider, H. J. Burtscher, B. Auer, M. HirschKauffmann, and M. Schweiger. 1985. Transient expression of a plasmid gene, a tool to study DNA repair in human cells: defect of DNA repair in Cockayne syndrome; one pyrimidine cyclobutane dimer is sufficient to block transcription. Eur. J. Cell Biol. 39:346–351.
   Google Scholar
• Lai, G. M., R. F. Ozols, J. F. Smyth, R. C. Young, and T. C. Hamilton. 1988. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem. Pharmacol. 37:4597–4600.
   PubMed Web of Science ®Google Scholar
• Lehmann, A. R., and A. Oomen. 1985. Effect of DNA damage on the expression of the chloramphenicol acetyltransferase gene after transfection into diploid human fibroblasts. Nucleic Acids Res. 13:2087–2095.
   PubMed Web of Science ®Google Scholar
• Loehrer, P., and L. H. Einhorn. 1984. Cisplatin. Ann. Intern. Med. 100:704–713.
   PubMed Web of Science ®Google Scholar
• Masuda, H., R. F. Ozols, G. M. Lai, A. Fojo, M. Rothenberg, and T. C. Hamilton. 1988. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum(II) in human ovarian cancer cell lines. Cancer Res. 48:5713–5716.
   PubMed Web of Science ®Google Scholar
• Micetich, K., L. A. Zwelling, and K. W. Kohn. 1983. Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diammine dichloroplatinum(II) in L1210 cells. Cancer Res. 43:3609–3613.
   PubMedGoogle Scholar
• Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55–63.
   PubMed Web of Science ®Google Scholar
• Okayama, H., and P. Berg. 1982. High-efficiency cloning of full-length cDNA. Mol. Cell. Biol. 2:161–170.
   PubMed Web of Science ®Google Scholar
• Patterson, M., and G. Chu. 1989. Evidence that xeroderma pigmentosum cells from complementation group E are deficient in a homolog of yeast photolyase. Mol. Cell. Biol. 9:5105–5112.
   PubMedGoogle Scholar
• Plooy, A. C. M., M. van Dijk, and P. H. M. Lohman. 1984. Induction and repair of DNA cross-links in Chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity. Cancer Res. 44:2043–2051.
   PubMed Web of Science ®Google Scholar
• Protic-Sabljic, M., and K. H. Kraemer. 1985. One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells. Proc. Natl. Acad. Sci. USA 82:6622–6626.
   PubMedGoogle Scholar
• Rosenberg, B. 1985. Fundamental studies with cisplatin. Cancer 55:2303–2316.
   PubMed Web of Science ®Google Scholar
• Rosenstein, B. S., and C. C.-K. Chao. 1985. Isolation of a mutant cell line derived from ICR2A frog cells hypersensitive to the induction of nondimer DNA damage by solar ultraviolet radiation. Somatic Cell Mol. Genet. 11:339–344.
   PubMedGoogle Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Sheibani, N., M. M. Jennerwein, and A. Eastman. 1989. DNA repair in cells sensitive and resistant to cis-diamminedicnloro- platinum(II): host cell reactivation of damaged plasmid DNA. Biochemistry 28:3120–3124.
   PubMedGoogle Scholar
• Stark, G. R. 1986. DNA amplification in drug resistant cells and in tumours. Cancer Surv. 5:1–23.
   PubMedGoogle Scholar
• Stark, G. R., and G. M. Walh. 1984. Gene amplification. Annu. Rev. Biochem. 53:447–491.
   PubMed Web of Science ®Google Scholar
• Ushay, H. M., T. D. Tullius, and S. J. Lippard. 1981. Inhibition of the BamHI cleavage and unwinding of pBR322 DNA by the antitumor drug cis-dichlorodiammineplatinum(II). Biochemistry 20:3744–3748.
   PubMed Web of Science ®Google Scholar
• Wright, J. A., H. S. Smith, F. M. Watt, M. C. Hancock, D. L. Hudson, and G. R. Stark. 1990. DNA amplification is rare in normal human cells. Proc. Natl. Acad. Sci. USA 87:1791–1795.
   PubMed Web of Science ®Google Scholar
• Zwelling, L. A., T. Anderson, and K. W. Kohn. 1979. DNAprotein and DNA interstrand crosslinking by cis- and transplatinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res. 39:365–369.
   PubMed Web of Science ®Google Scholar
• Zwelling, L. A., S. Michaels, H. Schwartz, P. P. Dobson, and K. W. Kohn. 1981. DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diam- minedichloroplatinum(II) and L-phenylalanine mustard. Cancer Res. 41:640–649.
   PubMed Web of Science ®Google Scholar